Treatment with anti-factor VIIa in acute pancreatitis in rats: Blocking both coagulation and inflammation?

References

• Bone RC. Modulators of coagulation. A critical appraisal of their role in sepsis. Arch Intern Med 1992; 152: 1381–9
   PubMedGoogle Scholar
• Edwards RL, Rickies FR. Delayed hypersensitivity in man: effects of systemic anticoagulation. Science 1978; 200: 541–3
   PubMed Web of Science ®Google Scholar
• Kakakios AM, Ryan J, Geczy CL. Effects of locally administered heparins on delayed, type hypersensitivity reactions. Int Arch Allergy Appl Immunol 1990; 93: 300–7
   PubMedGoogle Scholar
• Cirino G, Cicala C, Bucci MR, Sorrentino L, Maraganore JM, Stone SR. Thrombin as an inflammatory mediator through activation of its receptor. J Exp Med 1996; 182: 821–7
   Google Scholar
• Tapparelli C, Metternich R, Ehrhardt C, Cook NS. Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile. Trends Pharmacol Sci 1993; 14: 366–76
   PubMed Web of Science ®Google Scholar
• Hoffman M, Monroe DM. 3rd. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958–65
   PubMed Web of Science ®Google Scholar
• Ferrara JJ, Kan C, Luterman A, Curreri PW. Effects of fibrinogen degradation fragments D and E on cell-mediated immunity. J Surg Res 1989; 47: 134–7
   PubMedGoogle Scholar
• Bar-Shavit R, Kahn A, Mudd MS, Wilner GD, Mann KG, Fenton JW. Localisation of a chemotactic domain in human thrombin. Biochemistry 1985; 23: 397–400
   Google Scholar
• Senior RM, Skogen WF, Griffen GL, Wilner GD. Effects of fibrinogen derivatives upon the inflammatory response. J Clin Invest 1986; 77: 1014–9
   PubMed Web of Science ®Google Scholar
• Camerer E, Rottingen J-A, Iversen J-G, Prydz H. Coagulation factors VII and X induce Ca 2+ oscillations in Madin-Darby canine kidney cells only when proteolytically active. J Biol Chem 1996; 271: 29034–42
   PubMedGoogle Scholar
• Poulsen LJ, Jacobsen N, Sorensen BB, Bergenhem NCH, Kelly JD, Foster DC, et al. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation FVII to tissue factor. J Biol Chem 1998; 273: 6228–32
   PubMed Web of Science ®Google Scholar
• Sorensen BB, Freskgard P, Nielsen LS, Rao LVM, Ezban M, Petersen LC. FVIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of FVIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 1999; 274: 21349–54
   PubMed Web of Science ®Google Scholar
• Camerer E, Gjernes E, Wigert MT, Pringle S, Prytz H. Binding of FVIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem 2000; 275: 6580–5
   PubMedGoogle Scholar
• Taylor FB, Jr, Chang AC, Peer GT, Li A, Ezban M, Hedner U. Active site inhibited FVIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumour necrosis factor, responses of the baboon to LD100 Escherichia coli. Blood 1998; 91: 1609–15
   PubMed Web of Science ®Google Scholar
• Taylor FB, Jr, Chang A, Ruf W, Morrisey JH, Hinshaw L, Catlett R, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127–34
   PubMedGoogle Scholar
• Taylor FB, Jr, Chang AC, Peer GT, Mather T, Blick K, Catlett R, et al. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood 1991; 78: 364–8
   PubMed Web of Science ®Google Scholar
• Carraway MS, Welthy-Wolf KE, Miller DL, Ortel TL, Idell S, Ghio AJ, et al. Blockade of tissue factor: a rescue strategy for multi-organ failure in established sepsis. Am J Respir Cri Care Med 2003; 176: 1200–9
   Google Scholar
• Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol 1997; 38: 205–27
   PubMedGoogle Scholar
• Oka S, Kamata H, Kamata K, Yagisawa H, Hirata H. N-acetylcysteine suppresses TNF-induced NF-B activation through inhibition of IB kinases. FEBS Lett 2000; 472: 196–202
   PubMed Web of Science ®Google Scholar
• Kim H, Seo J, Roh KH, Lim JW, Kim KH. Suppression of NF-B activation and cytokine production by N-acetylcysteine in pancreatic acinar cells. Free Radic Biol Med 2000; 29: 674–83
   PubMedGoogle Scholar
• Wang XD, Deng XM, Haraldsen P, Andersson R, Ihse I. Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in the rats. Scand J Gastroenterol 1995; 30: 1129–36
   PubMed Web of Science ®Google Scholar
• Sevillano S, de la Mano AM, De Dios I, Ramudo L, Manso MA. Major pathological mechanisms of acute pancreatitis are prevented by N-acetylcysteine. Digestion 2003; 68: 34–40
   PubMedGoogle Scholar
• Demols A, Van Laethem JL, Quertinmont E, Legros F, Louis H, Le Moine O, et al. N-acetylcysteine decreases severity of acute pancreatitis in mice. Pancreas 2000; 20: 161–9
   PubMed Web of Science ®Google Scholar
• Inagaki T, Hoshino M, Hayakawa T, Ohara H, Yamada T, Yamada H, et al. Interleukin-6 is a useful marker for early prediction of the severity of acute pancreatitis. Pancreas 1997; 14: 1–8
   PubMedGoogle Scholar
• Carr C, Bild GS, Chang ACK, Peer GT, Palmier MO, Frazier RB, et al. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in a baboon Gram-negative model of septic shock. Circ Shock 1994; 44: 126–37
   PubMedGoogle Scholar
• Standiford TJ, Kunkel SL, Greenberger MJ, Laichalk LL, Strieter RM. Expression and regulation of chemokines in bacterial pneumonia. J Leuk Biol 1996; 59: 24–8
   PubMed Web of Science ®Google Scholar
• Martinez-Mier G, Toledo-Pereyra LH, McDuffie JE, Warner RL, Hsiao C, Staleton SR, et al. Exogenous nitric oxide downregulates MIP-2 and MIP-1 alpha chemokines and MAPK p44/42 after ischemia and reperfusion of the rat kidney. J Invest Surg 2002; 15: 287–96
   PubMed Web of Science ®Google Scholar
• Kojima Y, Suzuki S, Tsuchiya Y, Konno H, Baba S, Nakamura S. Regulation of pro-inflammatory and anti-inflammatory cytokine responses by Kuppfer cells in endotoxin-enhanced reperfusion injury after total hepatic ischemia. Transpl Int 2003; 16: 231–40
   PubMedGoogle Scholar
• Pastor CM, Rubbia-Brandt L, Hadengue A, Jordan M, Morel P, Frossard JL. Role of macrophage inflammatory protein-2 in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury. Lab Invest 2003; 83: 471–8
   PubMed Web of Science ®Google Scholar
• Gray KD, Simovic MO, Chapman WC, Blackwell TS, Christman JW, May AK, et al. Endotoxin potentiates lung injury in cerulein-induced pancreatitis. Am J Surg 2003; 86: 526–30
   Google Scholar
• Bradley PP, Priebat DA, Christensen RD, Rohstein G. Measurement of cutaneous inflammation: estimation pf neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206–9
   PubMed Web of Science ®Google Scholar
• Komatsu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inoue M, et al. Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol 1992; 262: G669–76
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709
   PubMed Web of Science ®Google Scholar
• Taylor FB, Jr, Chang A, Ruf W, Morrisey JH, Hinshaw L, Catlett R, et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127–34
   PubMedGoogle Scholar
• Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Buller HR, et al. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114–20
   PubMed Web of Science ®Google Scholar
• Biemond BJ, Levi M, ten Cate H, Soule HR, Morris LD, Foster DL, et al. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb Hemost 1995; 73: 223–30
   PubMed Web of Science ®Google Scholar
• Johanson K, Aarden L, Choi Y, de Groot E, Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87: 5051–60
   PubMedGoogle Scholar
• Creasy AA, Chang ACK, Feigen L, Wun TC, Taylor FB, Jr, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from Escherichia Coli septic shock. J Clin Invest 1993; 91: 2850–60
   PubMedGoogle Scholar
• Alfasser G, Warshaw AL, Thayer SP, Antoniu B, Laposata M, Lewandrowski K, et al. Activated protein C decreases inflammation and improves survival in experimental acute pancreatitis. Pancreatology 2004; 3–4: 284
   Google Scholar
• Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 1994; 20: 473–90
   PubMed Web of Science ®Google Scholar
• Tekamp-Olson P, Gallegos C, Bauer D, McClain J, Sherry B, Fabre M, et al. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologues. J Exp Med 1990; 172: 911–9
   PubMed Web of Science ®Google Scholar
• Ludwicka-Bradley A, Tourkina E, Suzuki S, Tyson E, Bonner M, Fenton JW, et al. Thrombin upregulates interleukin-8 in lung fibroblasts via cleavage of proteolytically activated receptor-I and protein kinase C-gamma activation. Am J Resp Cell Mol Biol 2000; 22: 235–43
   PubMedGoogle Scholar
• Wang XL, Gjernes E, Prydz H. Factor VIIa induces tissue-factor dependent up-regulation of interleukin-8 in a human keratinocyte line. J Biol Chem 2002; 277: 23620–6
   PubMedGoogle Scholar